Lilly (Eli) & Co. Contracts & Agreements

142 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Form of Shareholder Value Award under the 2002 Lilly Stock Plan
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2025
Form of Relative Value Award under the 2002 Lilly Stock Plan
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2025
Form of Restricted Stock Unit Award under the 2002 Lilly Stock Plan
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2025
The Lilly Deferred Compensation Plan, as amended
Lilly (Eli) & Co.
Pharmaceuticals
2025
The Lilly Directors' Deferral Plan, as amended
Lilly (Eli) & Co.
Pharmaceuticals
2025
Underwriting Agreement, dated February 10, 2025, among Eli Lilly and Company and Barclays Capital Inc., BofA Securities, Inc., Citigroup Global Markets Inc., Deutsche Bank...
Underwriting Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2025
Form of Officers' Certificate setting forth the terms and form of the Notes
Note Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2025
Underwriting Agreement, dated August 12, 2024, among Eli Lilly and Company and BNP Paribas Securities Corp., Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, J.P. Morgan...
Underwriting Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2024
Form of Officers Certificate setting forth the terms and form of the Notes
Note Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2024
Amended and Restated 2002 Lilly Stock Plan
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2024
Description of the Company's Common Stock
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2024
Form of Shareholder Value Award under the 2002 Lilly Stock Plan
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2024
Form of Relative Value Award under the 2002 Lilly Stock Plan
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2024
Form of Restricted Stock Unit Award under the 2002 Lilly Stock Plan
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2024
2007 Change in Control Severance Pay Plan for Select Employees, as amended
Change of Control Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2024
Underwriting Agreement, dated February 7, 2024, among Eli Lilly and Company and BofA Securities, Inc., Barclays Capital Inc., Citigroup Global Markets Inc., Deutsche Bank...
Underwriting Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2024
Form of Officers Certificate setting forth the terms and form of the Notes
Note Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2024
Underwriting Agreement, dated February 23, 2023, among Eli Lilly and Company and J.P. Morgan Securities LLC, Credit Suisse Securities (USA) LLC, Goldman Sachs & Co. LLC and Morgan...
Underwriting Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2023
Form of Officers Certificate setting forth the terms and form of the Notes
Note Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2023
Form of Performance Award under the 2002 Lilly Stock Plan
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2023
Form of Shareholder Value Award under the 2002 Lilly Stock Plan
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2023
Form of Relative Value Award under the 2002 Lilly Stock Plan
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2023
Form of Non-Compete Payment Agreement
Non-Competition Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2023
Form of Performance Award under the 2002 Lilly Stock Plan (with non-compete)
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2022
Form of Shareholder Value Award under the 2002 Lilly Stock Plan (with non-compete)
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2022
Form of Relative Value Award under the 2002 Lilly Stock Plan (with non-compete)
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2022
Description of the Company's 0.500% Notes due 2033, 1.125% Notes due 2051, and 1.375% Notes due 2061
Note Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2022
Description of the Company's 1.625% Notes due 2043
Note Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2022
Form of Performance Award under the 2002 Lilly Stock Plan
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2022
Form of Performance Award under the 2002 Lilly Stock Plan (with non-compete)
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2022
Form of Performance Award under the 2002 Lilly Stock Plan (non-executive officer)
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2022
Form of Shareholder Value Award under the 2002 Lilly Stock Plan
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2022
Form of Shareholder Value Award under the 2002 Lilly Stock Plan (with non-compete)
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2022
Form of Shareholder Value Award under the 2002 Lilly Stock Plan (non-executive officer)
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2022
Form of Relative Value Award under the 2002 Lilly Stock Plan
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2022
Form of Relative Value Award under the 2002 Lilly Stock Plan (with non-compete)
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2022
Form of Relative Value Award under the 2002 Lilly Stock Plan (non-executive)
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2022
Form of Restricted Stock Unit Award under the 2002 Lilly Stock Plan
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2022
The Loxo Oncology, Inc. Bonus Plan
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2022
Underwriting Agreement, dated September 8, 2021, among Eli Lilly and Company and Merrill Lynch International, Barclays Bank PLC, BNP Paribas, Citigroup Global Markets Limited and...
Underwriting Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2021
Form of Officers Certificate setting forth the terms and form of the Notes
Note Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2021
Form of Restricted Stock Unit Award under the 2002 Lilly Stock Plan (with non-compete)
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2021
Release Agreement, effective as of February 9, 2021, by and between Eli Lilly and Company and Joshua L. Smiley
Release Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2021
Form of Performance Award under the 2002 Lilly Stock Plan
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2021
Form of Performance Award under the 2002 Lilly Stock Plan (with non-compete)
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2021
Form of Performance Award under the 2002 Lilly Stock Plan (non-executive officer)
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2021
Form of Shareholder Value Award under the 2002 Lilly Stock Plan
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2021
Form of Shareholder Value Award under the 2002 Lilly Stock Plan (with non-compete)
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2021
Form of Shareholder Value Award under the 2002 Lilly Stock Plan (non-executive officer)
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2021
Form of Relative Value Award under the 2002 Lilly Stock Plan
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2021
Form of Relative Value Award under the 2002 Lilly Stock Plan (with non-compete)
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2021
Form of Restricted Stock Unit Award under the 2002 Lilly Stock Plan
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2021
The Eli Lilly and Company Bonus Plan, as amended
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2021
2007 Change in Control Severance Pay Plan for Select Employees, as amended
Change of Control Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2021
Underwriting Agreement, dated August 20, 2020, among the Company and BNP Paribas Securities Corp., Citigroup Global Markets Inc., J.P. Morgan Securities LLC and Morgan Stanley &...
Underwriting Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2020
Form of Officers Certificate setting forth the terms and form of the 2060 Notes and certain matters with respect to the New 2050 Notes
Note Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2020
Underwriting Agreement
Underwriting Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2020
Form of Officers Certificate setting forth the terms and form of the Notes
Note Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2020
Description of the Company's Common Stock
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2020
Description of the Company's 1.000% EUR Notes due 2022, 1.625% EUR Notes due 2026, and 2.125% EUR Notes due 2030
Note Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2020
Description of the Company's 6.77% Notes due 2036
Note Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2020
Description of the Company's 7 1/8% Notes due 2025
Note Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2020
Description of the Company's 0.625% EUR Notes due 2031 and 1.700% EUR Notes due 2049
Note Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2020
Form of Performance Award under the 2002 Lilly Stock Plan
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2020
Form of Shareholder Value Award under the 2002 Lilly Stock Plan
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2020
Form of Relative Value Award under the 2002 Lilly Stock Plan
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2020
Restricted Stock Unit Award to Michael Harrington under the 2002 Lilly Stock Plan
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2020
Underwriting Agreement
Underwriting Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2019
Form of Officers Certificate setting forth the terms and form of the Notes
Note Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2019
Underwriting Agreement
Underwriting Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2019
Form of Officers Certificate setting forth the terms and form of the Notes
Note Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2019
Form of Performance Award under the 2002 Lilly Stock Plan
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2019
Form of Shareholder Value Award under the 2002 Lilly Stock Plan
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2019
2002 Lilly Stock Plan, as amended
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2018
Form of Performance Award under the 2002 Lilly Stock Plan
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2018
Form of Shareholder Value Award under the 2002 Lilly Stock Plan
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2018
Underwriting Agreement
Underwriting Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2017
ELI LILLY AND COMPANY Officers Certificate Pursuant to Section 3.01 of the Indenture May [__], 2017
Indenture Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2017
Eli Lilly and Company Performance Award (for Executive Officers)
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2017
Eli Lilly and Company Shareholder Value Award (for Executive Officers)
Shareholders Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2017
Eli Lilly and Company Shareholder Value Award (for Executive Officers)
Shareholders Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2016
Underwriting Agreement
Underwriting Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2015
Eli Lilly And Company Officers Certificate Pursuant to Section 3.01 of the Indenture June 2, 2015
Indenture Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2015
Underwriting Agreement
Underwriting Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2015
Eli Lilly And Company Officers Certificate Pursuant to Section 3.01 of the Indenture March [ ], 2015
Indenture Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2015
FIRST AMENDMENT TO STOCK AND ASSET PURCHASE AGREEMENT
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2015
Eli Lilly and Company Performance Award (for Executive Officers)
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2015
Eli Lilly and Company Shareholder Value Award (for Executive Officers)
Shareholders Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2015
Underwriting Agreement
Underwriting Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2014
Eli Lilly And Company Officers Certificate Pursuant to Section 3.01 of the Indenture February [ ], 2014
Indenture Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2014
ELI LILLY AND COMPANY THE LILLY DEFERRED COMPENSATION PLAN (as Amended and Restated Effective 1/1/2009)
Compensation Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2014
The Eli Lilly and Company Bonus Plan (as amended effective January 1, 2014)
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2014
The Eli Lilly and Company Bonus Plan (as amended effectiveJanuary 1, 2011) TABLE OF CONTENTS
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2011
Eli Lilly and Company Performance Award (for Executive Officers)
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2010
Eli Lilly and Company Restricted Stock Unit (for Executive Officers)
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2010
Eli Lilly and Company Shareholder Value Award
Shareholders Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2010
The Eli Lilly and Company Bonus Plan
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2010
Underwriting Agreement
Underwriting Agreements
Lilly (Eli) & Co.
Pharmaceuticals
NY
2009
Underwriting Agreement
Underwriting Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2009
TRIPARTITE AGREEMENT
Lilly (Eli) & Co.
Pharmaceuticals
2009
The Eli Lilly and Company Bonus Plan (as amended January 1, 2009)
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2009
IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA UNITED STATES OF AMERICA : v. : CRIMINAL NO. ELI LILLY AND COMPANY :
Lilly (Eli) & Co.
Pharmaceuticals
2009
SETTLEMENT AGREEMENT
Settlement Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2009
CORPORATE INTEGRITY AGREEMENT between the Office of Inspector General of the Department of Health and Human Services and Eli Lilly and Company
Services Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2009
Regulation FD Disclosure
Lilly (Eli) & Co.
Pharmaceuticals
IN
2008
2002 LILLY STOCK PLAN As amended effective January 1, 2009
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2008
ELI LILLY AND COMPANY
Lilly (Eli) & Co.
Pharmaceuticals
NY
2008
ELI LILLY AND COMPANY
Lilly (Eli) & Co.
Pharmaceuticals
IN
2008
ELI LILLY AND COMPANY
Lilly (Eli) & Co.
Pharmaceuticals
IN
2008
ELI LILLY AND COMPANY
Lilly (Eli) & Co.
Pharmaceuticals
IN
2008
the Purchaser will commence a tender offer (the Offer) to acquire all of the outstanding shares of common stock, par value $0.001, of ImClone, and the associated preferred stock...
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
DE
2008
No Payout Level 1 Level 2 Level 3 Level 4 Level 5 Level 6 Stock Price $ [ ] $ [ ] $ [ ] $ [ ] $ [ ] $ [ ] $ [ ] $ [ ] $ [ ] $ [ ] % of Target 0 % 40 % 60 % 80 % 100 % 120 % 140 %
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2007
Underwriting Agreement
Underwriting Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2007
Form of 5.20% Note due 2017
Note Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2007
Form of 5.50% Note due 2027
Note Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2007
Form of 5.55% Note due 2037
Note Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2007
1994 LILLY STOCK PLAN, as amended through April 15, 2002
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2007
1998 LILLY STOCK PLAN As amended and restated effective October 15, 2001
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2007
The Eli Lilly and Company Bonus Plan
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2006
ELI LILLY AND COMPANY
Lilly (Eli) & Co.
Pharmaceuticals
2006
Bonus Plan, as amended
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2006
Summary of 2006 Compensation for Non-Employee Directors
Compensation Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2006
Summary of 2006 Compensation for Named Executive Officers
Compensation Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2006
The Eli Lilly and Company Bonus Plan, as Amended
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2005
Master Settlement Agreement
Settlement Agreements
Lilly (Eli) & Co.
Pharmaceuticals
NY
2005
ELI LILLY SERVICES, INC. as Issuer and ELI LILLY AND COMPANY as Guarantor and CITIBANK, N.A. as Trustee
Lilly (Eli) & Co.
Pharmaceuticals
DC
2005
Eli Lilly Services, Inc. Eli Lilly and Company Officers Certificate Pursuant to Section 3.01 of the Indenture
Indenture Agreements
Lilly (Eli) & Co.
Pharmaceuticals
NY
2005
Summary of 2005 Compensation for Non-Employee Directors
Compensation Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2005
Summary of 2005 Compensation for Named Executive Officers
Compensation Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2005
Letter concerning Retirement Benefits for Charles E. Golden
Retirement Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2005
Letter concerning Retirement Benefits For Steven M. Paul
Retirement Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2005
Arrangement Regarding Retirement Benefits
Retirement Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2005
Time Sharing Agreement
Lilly (Eli) & Co.
Pharmaceuticals
2005
Deferred Compensation Plan
Compensation Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2004
Change in Control Severance Pay Plan
Change of Control Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2004
2007 Change in Control Severance Pay Plan
Change of Control Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2004
Rights Agreement
Lilly (Eli) & Co.
Pharmaceuticals
NY
2004
The Lilly Deferred Compensation Plan
Compensation Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2004
The Lilly Directors' Deferral Plan
Lilly (Eli) & Co.
Pharmaceuticals
IN
2004
GlobalShares Stock Plan, as amended
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2003
Form of 2.90 Percent Note Due 2008
Note Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2003
Form of 4.50 Percent Note Due 2018
Note Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2003